Date Title Description PDF
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download

Pages

20 / 41
Date Title Description PDF
10 May 2023 Announcement of General Shareholders’ Meeting ROVI releases the information related to its General Shareholders Meeting Download
10 Apr 2023 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the first quarter of 2023 Download
21 Feb 2023 Annual Corporate Governance Report ROVI releases the 2022 Annual Corporate Governance Report Download
21 Feb 2023 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2022 annual report regarding remuneration of the members of the Board of Directors Download
16 Feb 2023 On business and financial situation The Company informs on the evaluation process to obtain marketing authorisation for Risvan® (Risperidone ISM®) in the United States. Download

Pages

65 / 150
Date Title Description PDF
09 Jun 2015 Convocatorias y Acuerdos de Juntas y Asambleas Generales Download
03 Jun 2015 Acuerdos estratégicos con terceros Download
06 May 2015 Convocatorias y Acuerdos de Juntas y Asambleas Generales Download
29 Apr 2015 Información sobre resultados (2) Download
29 Apr 2015 Información sobre resultados Download

Pages

130 / 194